Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in North East Scotland: The PINE study

Parkinsonism and Related Disorders

Volumn 19, Issue 5, 2013, Pages 515-521

  Caslake, Robert ^a   Taylor, Kate ^b   Scott, Neil ^a   Gordon, Joanna ^a   Harris, Clare ^a   Wilde, Katie ^a   Murray, Alison ^a   Counsell, Carl ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b RAIGMORE HOSPITAL   (United Kingdom)

Author keywords

Incidence; Meta analysis; Parkinson's disease; Parkinsonism; Social class

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DRUG INDUCED DISEASE; DRUG INDUCED PARKINSONISM; ESSENTIAL TREMOR; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; SEX RATIO; SOCIOECONOMICS; SYSTEMATIC REVIEW; UNITED KINGDOM; VASCULAR PARKINSONISM;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PARKINSON DISEASE; PARKINSONIAN DISORDERS; PILOT PROJECTS; PROSPECTIVE STUDIES; SCOTLAND; SEX FACTORS; SOCIAL CLASS;

EID: 84875538666     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2013.01.014     Document Type: Article

References (36)

1. Twelves D., Perkins K.S., Counsell C. Systematic review of incidence studies of Parkinson's disease. Mov Disord 2003, 18:19-31.
2. Rajput A.H., Rozdilsky B., Rajput A. Accuracy of clinical diagnosis in parkinsonism-a prospective study. Can J Neurol Sci 1991, 18:275-278.
3. Caslake R., Moore J.N., Gordon J.C., Harris C.E., Counsell C. Changes in diagnosis with follow-up in an incident cohort of patients with parkinsonism. J Neurol Neurosurg Psychiatr 2008, 79:1202-1207.
4. Mutch W.J., Dingwall-Fordyce I., Downie A.W., Paterson J.G., Roy S.K. Parkinson's disease in a Scottish city. BMJ 1986, 292:534-536.
5. Taylor K.S.M., Counsell C.E., Harris C.E., Gordon J.C., Smith W.C.S. Pilot study of the incidence and prognosis of degenerative Parkinsonian disorders in Aberdeen, United Kingdom: methods and preliminary results. Mov Disord 2006, 21:976-982.
6. Taylor K.S., Counsell C.E., Harris C.E., Gordon J.C. Screening for undiagnosed parkinsonism in people aged 65 years and over in the community. Parkinsonism Relat Disord 2006, 12:79-85.
7. Taylor K.S., Counsell C.E., Gordon J.C., Harris C.E. Screening for undiagnosed parkinsonism among older people in general practice. Age Ageing 2005, 34:501-504.
8. Fahn S., Elton R.L. Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. Recent developments in Parkinson's disease 1987, vol. 2:153-163. Macmillan Health Care Information, Florham Park, NewJersey.
9. Chaudhuri K.R., Buxton-Thomas M., Dhawan V., Peng R., Meilak C., Brooks D.J. Long duration asymmetrical postural tremor is likely to predict development of Parkinson's disease and not essential tremor: clinical follow up study of 13 cases. J Neurol Neurosurg Psychiatr 2005, 76:115-117.
10. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatr 1992, 55:181-184.
11. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., et al. Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 2005, 65:1863-1872.
12. Gilman S., Wenning G.K., Low P.A., Brooks D.J., Mathias C.J., Trojanowski J.Q., et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008, 71(9):670-676.
13. Litvan I., Agid Y., Calne D., Campbell G., Dubois B., Duvoisin R.C., et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology 1996, 47:1-9.
14. Zijlmans J.C.M., Daniel S.E., Hughes A.J., Revesz T., Lees A.J. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 2004, 19:630-640.
15. Lang A.E., Riley D.E., Bergeron C. Cortico-basal ganglionic degeneration. Neurodegenerative diseases 1994, 877-894. WB Saunders Co, Philadelphia. D.B. Calne (Ed.).
16. Riley D.E., Lang A.E. Clinical diagnostic criteria. Corticobasal degeneration and related disorders 2000, 29-34. WB Saunders, Philadelphia. I. Litvan, C.G. Goetz, A.E. Lang (Eds.).
17. Carstairs V., Morris R. Deprivation and health in Scotland. Health Bull 1990, 48:162-175.
18. McLoone P. Carstairs scores for Scottish postcode sectors from the 2001 Census 2004, MRC Social and Public Health Sciences Unit, Glasgow.
19. MacDonald B.K., Cockerell O.C., Sander J.W., Shorvon S.D. The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000, 123:665-676.
20. Linder J., Stenlund H., Forsgren L. Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study. Mov Disord 2010, 25:341-348.
21. Mayeux R., Marder K., Cote L.J., Denaro J., Hemenegildo N., Mejia H., et al. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol 1995, 142:820-827.
22. Kuopio A.M., Marttila R.J., Helenius H., Rinne U.K. Changing epidemiology of Parkinson's disease in southwestern Finland. Neurology 1999, 52:302-308.
23. Marttila R.J., Rinne U.K. Epidemiology of Parkinson's disease in Finland. Acta Neurol Scand 1976, 53:81-102.
24. Taba P., Asser T. Incidence of Parkinson's disease in Estonia. Neuroepidemiology 2003, 22:41-45.
25. Foltynie T., Brayne C.E.G., Robbins T.W., Barker R.A. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 2004, 127:550-560.
26. Alves G., Muller B., Herlofson K., HogenEsch I., Telstad W., Aarsland D., et al. Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatr 2009, 80:851-857.
27. Hristova D., Zachariev Z., Mateva N., Grozdev I. Incidence of Parkinson's disease in Bulgaria. Neuroepidemiology 2010, 34:76-82.
28. Winter Y., Bezdolnyy Y., Katunina E., Avakjan G., Reese J.P., Klotsche J., et al. Incidence of Parkinson's disease and atypical parkinsonism: Russian population-based study. Mov Disord 2010, 25:349-356.
29. Granieri E., Carreras M., Casetta I., Govoni V., Tola M.R., Paolino E., et al. Parkinson's disease in Ferrara, Italy, 1967 through 1987. Arch Neurol 1991, 48:854-857.
30. Taylor K.S., Cook J.A., Counsell C.E. Heterogeneity in male to female risk for Parkinson's disease. J Neurol Neurosurg Psychiatr 2007, 78:905-906.
31. Li X., Sundquist J., Sundquist K. Socioeconomic and occupational groups and Parkinson's disease: a nationwide study based on hospitalizations in Sweden. Int Arch Occup Environ Health 2009, 82:235-241.
32. Hernan M.A., Takkouche B., Caamano-Isorna F., Gestal-Otero J.J. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 2002, 52:276-284.
33. Benito-Leon J., Bermejo-Pareja F., Morales-Gonzalez J.M., Porta-Etessam J., Trincado R., Vega S., et al. Incidence of Parkinson disease and parkinsonism in three elderly populations of central Spain. Neurology 2004, 62:734-741.
34. Baldereschi M., Di Carlo A., Rocca W.A., Vanni P., Maggi S., Perissinotto E., et al. Parkinson's disease and parkinsonism in a longitudinal study: two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 2000, 55:1358-1363.
35. de Lau L.M., Giesbergen P.C., de Rijk M.C., Hofman A., Koudstaal P.J., Breteler M.M. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 2004, 63:1240-1244.
36. Scottish Intercollegiate Guidelines Network Diagnosis and pharmacological management of Parkinson's disease 2010, NHS Quality Improvement for Scotland, Edinburgh.